Amanote Research
Register
Sign In
Off-Label Use in Lymphoma Patients in Switzerland
Hematological Oncology
- United Kingdom
doi 10.1002/hon.223_2631
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
A.K. Herbrand
A.M. Schmitt
M. Joerger
L.G. Hemkens
B. Kasenda
Publisher
Wiley
Related search
Off-Label Drug Use in Hospitalized Children
Archives of Pediatrics & Adolescent Medicine
«Off Label Use»: Nouvelles Recommandations
Bulletin des Médecins Suisses
Off-Label Use of Omalizumab in Pediatric Anaphylaxis
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Methylphenidate Off-Label Use and Safety
SpringerPlus
Multidisciplinary
Off-Label Use of Rituximab in Dermatology: Pemphigus Treatment
Anais Brasileiros de Dermatologia
Dermatology
Off-Label Use of Anticancer Drugs in South Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Off-Label Use of Approved Drugs
Nature Reviews Clinical Oncology
Oncology
Trends in Off-Label Drug Use in Ambulatory Settings: 2006–2015
Pediatrics
Child Health
Pediatrics
Perinatology
Off-Label Use of Clonidine for Sedation in Dutch ICUs
Critical Care
Critical Care
Intensive Care Medicine